10.42
price down icon0.57%   -0.06
after-market Handel nachbörslich: 10.42
loading
Schlusskurs vom Vortag:
$10.48
Offen:
$10.47
24-Stunden-Volumen:
236.56K
Relative Volume:
0.83
Marktkapitalisierung:
$388.01M
Einnahmen:
$65.42M
Nettoeinkommen (Verlust:
$-32.96M
KGV:
-8.2047
EPS:
-1.27
Netto-Cashflow:
$-19.87M
1W Leistung:
-1.42%
1M Leistung:
-20.09%
6M Leistung:
-10.02%
1J Leistung:
+44.12%
1-Tages-Spanne:
Value
$10.20
$10.60
1-Wochen-Bereich:
Value
$10.10
$11.53
52-Wochen-Spanne:
Value
$5.45
$18.98

Neuropace Inc Stock (NPCE) Company Profile

Name
Firmenname
Neuropace Inc
Name
Telefon
(650) 237-2700
Name
Adresse
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Name
Mitarbeiter
195
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
NPCE's Discussions on Twitter

Vergleichen Sie NPCE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
NPCE
Neuropace Inc
10.42 388.01M 65.42M -32.96M -19.87M -1.27
Medical Devices icon
ABT
Abbott Laboratories
134.11 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
103.63 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
391.81 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
88.28 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.02 44.46B 5.54B 4.18B 623.10M 7.00

Neuropace Inc Stock (NPCE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-28 Eingeleitet H.C. Wainwright Buy
2025-01-21 Eingeleitet UBS Buy
2024-03-14 Hochstufung Wells Fargo Equal Weight → Overweight
2024-01-30 Eingeleitet Leerink Partners Outperform
2023-11-10 Eingeleitet Cantor Fitzgerald Overweight
2023-08-24 Hochstufung Morgan Stanley Underweight → Equal-Weight
2023-02-22 Eingeleitet Lake Street Buy
2022-04-06 Eingeleitet Wolfe Research Outperform
2022-01-19 Herabstufung Wells Fargo Overweight → Equal Weight
2022-01-07 Herabstufung Morgan Stanley Equal-Weight → Underweight
2021-11-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-08-18 Eingeleitet Robert W. Baird Outperform
2021-05-17 Eingeleitet JP Morgan Overweight
2021-05-17 Eingeleitet Morgan Stanley Overweight
2021-05-17 Eingeleitet SVB Leerink Outperform
2021-05-17 Eingeleitet Wells Fargo Overweight
Alle ansehen

Neuropace Inc Aktie (NPCE) Neueste Nachrichten

pulisher
Jun 18, 2025

NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey - MSN

Jun 18, 2025
pulisher
Jun 16, 2025

Metric Analysis: NeuroPace Inc (NPCE)’s Key Ratios in the Limelight - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

NeuroPace stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com India

Jun 16, 2025
pulisher
Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc.NPCE - FinancialContent

Jun 15, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Invests $293,000 in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Cantor Fitzgerald Comments on NeuroPace FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Bank of America Corp DE Raises Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 13, 2025
pulisher
Jun 12, 2025

Research Analysts Set Expectations for NeuroPace Q2 Earnings - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

NeuroPace Holds Virtual Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

NeuroPace’s SWOT analysis: med tech stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

NeuroPace’s SWOT analysis: med tech stock poised for growth amid challenges - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

NeuroPace Inc (NPCE) Shares Down 3.25% on Jun 12 - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Potential Securities Fraud: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

NeuroPace stock maintains buy rating at UBS following physician survey By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

NeuroPace stock maintains buy rating at UBS following physician survey - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates NeuroPace FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Fraud Investigation: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) on Behalf of Shareholders - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 11, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 11, 2025

Two Sigma Investments LP Makes New Investment in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 10, 2025

NPCE ALERT: Ongoing Investigation Into NeuroPace, Inc.Contact Levi & Korsinsky - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 09, 2025

Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) Over Possible Securities Fraud - ACCESS Newswire

Jun 09, 2025
pulisher
Jun 09, 2025

Did NeuroPace, Inc. (NPCE) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

Jun 09, 2025
pulisher
Jun 09, 2025

Q2 Earnings Forecast for NeuroPace Issued By Leerink Partnrs - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Purchases New Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Ongoing Investigation into NeuroPace, Inc. (NPCE): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 05, 2025

NeuroPace secures USD 75M in debt financing - Medical Buyer

Jun 05, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Acquires New Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 04, 2025

NeuroPace Secures $75 Million Credit Facility with MidCap - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

NeuroPace Secures $75 Million Credit Facility From MidCap Financial - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

NeuroPace secures $75 million credit facility with MidCap Financial - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

NeuroPace secures $75 million credit facility with MidCap Financial By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Neuropace IncEnters Into Credit Agreement With Midcap Funding Iv Trust - MarketScreener

Jun 04, 2025
pulisher
Jun 04, 2025

NeuroPace Secures Up to $75 Million in Debt Financing - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

NeuroPace, Inc. Secures $75 Million Credit Facility from MidCap Financial to Support Growth Initiatives - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

$75M Financing Fuels NeuroPace's Epilepsy Treatment Expansion: 5 Key Growth Initiatives Revealed - Stock Titan

Jun 04, 2025
pulisher
Jun 04, 2025

Lost Money on NeuroPace, Inc. (NPCE)? Contact Levi & Korsinsky About Investigation - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 03, 2025

Lost Investment in NeuroPace, Inc. (NPCE)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

FY2028 EPS Estimates for NeuroPace Cut by Leerink Partnrs - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

What is HC Wainwright's Forecast for NeuroPace Q2 Earnings? - MarketBeat

Jun 03, 2025
pulisher
Jun 02, 2025

NPCE ACTIVE INVESTIGATION: Lost Money on NeuroPace, Inc.? Contact Levi & Korsinsky Now - ACCESS Newswire

Jun 02, 2025
pulisher
Jun 02, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Stockholders to Connect - ACCESS Newswire

Jun 02, 2025
pulisher
Jun 02, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeuroPace, ... - Bluefield Daily Telegraph

Jun 02, 2025

Finanzdaten der Neuropace Inc-Aktie (NPCE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Neuropace Inc-Aktie (NPCE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Morrell Martha
CHIEF MEDICAL OFFICER
Feb 21 '25
Sale
13.72
78,334
1,074,844
81,993
KCK LTD.
10% Owner
Feb 20 '25
Sale
9.40
5,270,845
49,545,943
0
Morrell Martha
CHIEF MEDICAL OFFICER
Jan 30 '25
Sale
15.00
200
3,000
86,762
Morrell Martha
CHIEF MEDICAL OFFICER
Jan 29 '25
Sale
15.00
100
1,500
86,962
$301.62
price up icon 0.54%
medical_devices PHG
$24.52
price up icon 1.32%
medical_devices STE
$238.25
price down icon 1.82%
$83.58
price up icon 0.00%
$76.12
price up icon 0.22%
medical_devices EW
$77.02
price down icon 0.21%
Kapitalisierung:     |  Volumen (24h):